Loading…
Atossa Therapeutics, Inc. is projected to rise to $6.84 by 2027, a +34% move from its current price of $5.12. ATOS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.96 | $5.12 | $5.28 | +0.02% |
| May 30 | $4.90 | $5.12 | $5.35 | +0.03% |
| May 31 | $4.86 | $5.12 | $5.40 | +0.05% |
| Jun 1 | $4.82 | $5.12 | $5.45 | +0.07% |
| Jun 2 | $4.78 | $5.12 | $5.49 | +0.09% |
| Jun 3 | $4.75 | $5.13 | $5.53 | +0.10% |
| Jun 4 | $4.72 | $5.13 | $5.56 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.72 | $5.13 | $5.56 | +0.12% |
| Week 2 | $4.57 | $5.13 | $5.76 | +0.24% |
| Week 3 | $4.46 | $5.14 | $5.92 | +0.37% |
| Week 4 | $4.37 | $5.15 | $6.06 | +0.49% |
| Week 5 | $4.29 | $5.15 | $6.19 | +0.61% |
| Week 6 | $4.22 | $5.16 | $6.30 | +0.74% |
| Week 7 | $4.16 | $5.16 | $6.41 | +0.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas.
The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
ATOS is the stock trading in the Healthcare sector with a current price of $4.96 and a market capitalization of $42.71M. It holds a rank of 4661 by market cap. The asset’s 30-day range spans from $4.02 to $6.12, with near-term technicals showing a bearish tone overall.
A major floor 23.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.2% below — buyers have tended to step in here.
The nearest ceiling, 20.5% above — a clean break opens room to run.
A major ceiling 102.1% above — clearing it would confirm fresh momentum.
Key ATOS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATOS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.97 | Buy | $5.00 | Buy |
| MA 10 | $4.95 | Buy | $5.04 | Buy |
| MA 20 | $5.23 | Sell | $5.16 | Sell |
| MA 50 | $5.30 | Sell | $5.42 | Sell |
| MA 100 | $5.95 | Sell | $6.39 | Sell |
| MA 200 | $9.18 | Sell | $8.31 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.57 | Neutral |
| Stoch RSI (14) | 66.09 | Neutral |
| CCI (20) | -26.35 | Neutral |
| Williams %R (14) | -59.78 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -8.57 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 40.22 | Neutral |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | -0.41 | Sell |
| Ultimate (7,14,28) | 57.41 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 5.03 | Buy |
| ADX (14) | 13.27 | Neutral |
| ATR (14) | 0.14 | Info |
The near-term technical picture is bearish, with RSI(14) at 40. The 50-day simple moving average sits at $5.30 and the 200-day simple moving average at $9.24, framing resistance and support levels. Support is $4.75 and resistance is $6.17.
The stock’s 30-day range is $4.02 to $6.12, reflecting modest near-term volatility and a relatively tight trading window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.94 | $5.12 | $7.84 | 0% | Neutral | |
| $5.36 | $6.84 | $9.30 | +34% | Bullish | |
| $5.34 | $7.03 | $9.95 | +37% | Bullish | |
| $5.33 | $7.20 | $10.51 | +41% | Bullish | |
| $5.29 | $7.32 | $10.97 | +43% | Bullish | |
| $5.29 | $7.48 | $11.46 | +46% | Bullish | |
| $5.36 | $7.74 | $12.10 | +51% | Bullish | |
| $6.59 | $9.69 | $15.46 | +89% | Bullish | |
| $7.30 | $10.94 | $17.74 | +114% | Bullish | |
| $6.99 | $10.65 | $17.55 | +108% | Bullish | |
| $8.82 | $14.54 | $25.62 | +184% | Bullish | |
| $13.25 | $25.08 | $48.70 | +390% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.94 | $5.12 | $6.05 | +0.00% |
| June 2026 | $4.50 | $5.30 | $6.40 | +3.47% |
| July 2026 | $4.37 | $5.20 | $6.38 | -1.81% |
| August 2026 | $4.39 | $5.26 | $6.53 | +1.19% |
| September 2026 | $4.66 | $5.62 | $7.04 | +6.77% |
| October 2026 | $4.81 | $5.83 | $7.36 | +3.69% |
| November 2026 | $4.81 | $5.85 | $7.45 | +0.46% |
| December 2026 | $4.99 | $6.11 | $7.84 | +4.42% |
Click any year to see its month-by-month ATOS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ATOS is projected to trade between $3.94 and $7.84, averaging $5.12 — a potential gain of 0% from today's $5.12. Price action looks broadly range-bound.
Atossa Therapeutics, Inc.'s 2027 outlook centres on $6.84, within a $5.36 to $9.30 range. That is up +34% on the projected 2026 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ATOS could reach as high as $9.95, with a base case around $7.03 and support toward $5.34 — roughly +37% from $5.12. Momentum favours further upside here.
Expect ATOS to range from $5.33 to $10.51 through 2029. The $7.20 average target implies a +41% move from current prices. That is up +2% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ATOS price prediction for 2030 points to an average of $7.32 (low $5.29, high $10.97) — a potential gain of +43% on today's $5.12. Momentum favours further upside here.
In 2031, ATOS is projected to trade between $5.29 and $11.46, averaging $7.48 — a potential gain of +46% from today's $5.12. That is up +2% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Atossa Therapeutics, Inc.'s 2032 outlook centres on $7.74, within a $5.36 to $12.10 range. That is up +3% on the projected 2031 average. That marks a +51% change versus current levels. Momentum favours further upside here.
By 2033, ATOS could reach as high as $15.46, with a base case around $9.69 and support toward $6.59 — roughly +89% from $5.12. Buyers look set to stay in control over this stretch.
Expect ATOS to range from $7.30 to $17.74 through 2034. The $10.94 average target implies a +114% move from current prices. That is up +13% on the projected 2033 average. Momentum favours further upside here.
The ATOS price prediction for 2035 points to an average of $10.65 (low $6.99, high $17.55) — a potential gain of +108% on today's $5.12. Buyers look set to stay in control over this stretch.
In 2040, ATOS is projected to trade between $8.82 and $25.62, averaging $14.54 — a potential gain of +184% from today's $5.12. That is up +37% on the projected 2035 average. Momentum favours further upside here.
Atossa Therapeutics, Inc.'s 2050 outlook centres on $25.08, within a $13.25 to $48.70 range. That is up +73% on the projected 2040 average. That marks a +390% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ATOS today (≈ 195.3125 ATOS) could be worth
$4,899.41
+$3,899.41 (+390%) by 2050 · US Dollar
Based on the average projected ATOS price of $25.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATOSwould be worth at today's price.
$1,000 invested in ATOS on May 27, 2025 (≈ 79.365077 ATOS) would be worth
$406.35
-$593.65 (-59.4%) today · 0.41× · US Dollar
Based on a ATOS entry price of $12.6 vs. today's $5.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.84 | $1,057.85 | +5.8% |
| 1 month ago | $5.45 | $939.45 | -6.1% |
| 3 months ago | $4.47 | $1,145.41 | +14.5% |
| 6 months ago | $11.7 | $437.61 | -56.2% |
| 1 year ago | $12.6 | $406.35 | -59.4% |
| All time (5.0y) ago | $58.05 | $88.2 | -91.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATOS forecast.
Our base-case forecast reaches $10.00 around 2034.
Implied market cap at $10.00: $86.11M
The year-by-year forecast shows a path from a neutral start in 2026 to a bullish trajectory in later years. In 2026, the average forecast price is $4.96 with a min of $3.94 and a max of $7.65, and a 0% ROI indicating a neutral sentiment. From 2027 onward, the outlook turns bullish with rising averages and positive ROI: 2027 avg $6.57 (ROI 32.4%), 2028 avg $6.70 (ROI 35.1%), 2029 avg $6.90 (ROI 39.1%), and 2030 avg $6.85 (ROI 38.1%).
By 2033 the forecast climbs to an avg of $8.76 (ROI 76.6%), and by 2040 the avg reaches $12.80 (ROI 158.1%) with a max of $22.82. The long-horizon view projects a 2050 avg of $22.12 (ROI 345.9%) and a max of $43.52, all labeled with bullish sentiment. These are estimates and not guarantees.
Risks and uncertainties could influence actual outcomes.
Tap a question to reveal the answer.
In 2030, the average forecast price is $6.85 with a min of $4.91 and a max of $10.34, and a forecasted ROI of 38.1% with bullish sentiment.
The 2026 forecast shows a neutral stance with average price $4.96 and ROI 0%. From 2027 onward the outlook is bullish, with higher averages and ROI reaching 32.4% by 2027 and expanding to 345.9% by 2050.
Yes. The forecast max price reaches $22.82 in 2040 and $43.52 in 2050, indicating a path that could surpass $20.
The 2035 forecast shows an average price of $9.72 with a range from $6.31 to $16.19 and a forecasted ROI of 96%, with bullish sentiment.
Atossa Therapeutics, Inc. Community Discussion
0Share your Atossa Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.